In case you missed it: Updates from the Knight Cancer Institute

Testing the impact of reference pricing on cancer care

More than 15 million colonoscopies are performed in the U.S. each year as a routine cancer-prevention service, but did you know that the price for this procedure can vary by more than tenfold within a metropolitan area? David Lieberman, M.D., discusses the impact of reference pricing for colonoscopy services in a commentary in JAMA Internal Medicine. Find out more on Knight News.

MicroRNA as an early biomarker of leukemia

A preclinical study led by Peter Kurre, M.D., may point the way to more effective tests for recurrence of acute myeloid leukemia. Kurre and colleagues examined the efficacy of using exosomes in blood to reveal the presence of the disease before leukemia blast cells begin to circulate without the need to perform a marrow biopsy. Read more about this study — and the OHSU collaboration that made it possible — here.

Did you miss the Knight Challenge: Next Steps meeting?

Not to worry. Stay tuned to Knight News for an event recording and an online Q&A where you can get answers to any questions you have left.